Copyright
©The Author(s) 2016.
World J Gastroenterol. Jun 28, 2016; 22(24): 5495-5504
Published online Jun 28, 2016. doi: 10.3748/wjg.v22.i24.5495
Published online Jun 28, 2016. doi: 10.3748/wjg.v22.i24.5495
Balloon | Material | Volume | Weight loss1 | Note |
Fluid-supplied | ||||
Orbera (Apollo Endosurgery) | Silicone | 400-700 mL (saline) | 16.9 ± 0.9 kg (at 6 mo)[58] | Most widely used and studied intragastric balloon |
Volume adjustment at the time of placement | ||||
Spatz Adjustable Balloon system (Spatz FGIA) | Silicone | 400-600 mL (saline) | 24 kg (at 12 mo)[64] | Totally adjustable balloon |
Approved for 12 mo of implantation | ||||
ReShape Duo® Integrated DualBalloon System (ReShape medical) | Silicone | 900 mL (450 mL × 2) (saline) | 25.1 ± 1.6 %EWL (at 6 mo)[62] | Two independent balloons connected to silicone shaft |
The Elipse™ (Allurion Technologies) | N/A | 450-550 mL (filling fluid) | 2.4 kg (at 6 wk)[19] | Naturally swallowed, self-emptying, and naturally excreted |
Air-supplied | ||||
Obalon® Gastric Balloon (Obalon Therapeutics) | N/A | 250 mL (air, nitrogen) | 5 kg (at 12 wk)[66] | Can be swallowed |
A second or a third balloon can be swallowed depending on patient’s progress | ||||
Heliosphere BAG® (Helioscopie) | Polyurethane and silicone | 950 mL (air) | 16 ± 7 kg (at 6 mo)[23] | Less than 30 g |
Ref. | Balloon | Weight loss at 6 mo | Ghrelin (at 0 mo) | Ghrelin (after 3 mo) | Ghrelin (after 6 mo) | Ghrelin (after 12 mo) | Leptin (at 0 mo) | Leptin (after 3 mo) | Leptin (after 6 mo) | Leptin (after 12 mo) |
Mathus-Vliegen et al[17] | Orbera | 17.4 ± 7.8 kg | 722.3 ± 151.5 pg/mL | 791.5 ± 239.0 pg/mL | 743.7 ± 115.2 pg/mL | N/A | N/A | N/A | N/A | N/A |
Fuller et al[48] | N/A | 14.2% | 414.1 pmol/L | 448 pmol/L | 452.4 pmol/L | 379.4 pmol/L | 23.4 ng/mL | 18.5 ng/mL | 11.7 ng/mL | 19.7 ng/mL |
Bužga et al[85] | MedSil® | 18.4 ± 8.2 kg | 240.5 ± 101.5 μg/L | 378.1 ± 155.8 μg/L | 335.8 ± 149.2 μg/L | N/A | 30.4 ± 17.2 μg/L | 18.2 ± 15.8 μg/L | 14.9 ± 15.5 μg/L | N/A |
1Nikolic et al[86] | Orbera | N/A | 958.3 pg/mL | 1346.2 pg/mL | 1050.1 pg/mL | 922.6 pg/mL | 25.1 ng/mL | 14.3 ng/mL | 10.5 ng/mL | 17.5 ng/mL |
Konopko-Zubrzycka et al[39] | Orbera | 17.1 ± 8.0 kg | 621.9 ± 182.4 pg/mL | 903.9 ± 237 pg/mL (1 mo) | N/A | N/A | 61.3 ± 36.7 ng/mL | 39.9 ± 17.5 ng/mL (1 mo) | N/A | N/A |
Martinez-Brocca et al[79] | Orbera | 12.7 ± 5.6 kg (4 mo) | 934.4 ± 199.2 pg/mL | 947.1 ± 195.1 pg/mL (1 mo) | N/A | N/A | 31.9 ± 16.4 ng/mL | 22.4 ± 15.1 ng/mL (1 mo) | N/A | N/A |
Mion et al[78] | Orbera | 8.7 kg | 3.2 ± 0.4 ng/mL | N/A | 1.9 ± 0.1 ng/mL | N/A | 27.8 ± 3.7 ng/mL | N/A | 18.7 ± 2.7 ng/mL | N/A |
- Citation: Kim SH, Chun HJ, Choi HS, Kim ES, Keum B, Jeen YT. Current status of intragastric balloon for obesity treatment. World J Gastroenterol 2016; 22(24): 5495-5504
- URL: https://www.wjgnet.com/1007-9327/full/v22/i24/5495.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i24.5495